Clinical trial Recruiting at 1 site Observational Ages 35 to 75

Spinal Mobility, Rigidity, and Kinesiophobia in Parkinson's Disease with and without TMD

Official title: A Comparative Study of Spinal Mobility, Axial Rigidity, and Kinesiophobia Between Parkinson's Disease Patients With and Without Temporomandibular Disorders

Run by Mustafa Kemal University · NCT07850674 · Data updated 2026-11-12

This study tests whether people with Parkinson's disease who have Temporomandibular Disorders differ in spinal mobility, axial rigidity, and kinesiophobia from those without TMD.

More PARKINSON DISEASE (Disorder) trials

Quick facts

Study typeObservational
Ages35 Years to 75 Years
SexAll
Enrollment60 (estimated)
SponsorMustafa Kemal University
Academic / other
Locations1 site (Hatay)
StatusRecruiting
StartedSeptember 23, 2026
Main results expectedDecember 23, 2026
Study endsDecember 30, 2026
Registry record updatedOctober 5, 2026
Trial IDNCT07850674 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with Parkinson's disease aged 40–75, at Hoehn and Yahr stages 1.5–4, with MMSE ≥ 24, evaluated in the ON state.

Probably not a fit

PD patients without TMD or with severe comorbidities may not experience a clear benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will compare adults with Parkinson's disease, aged 40–75, who are in Hoehn and Yahr stages 1.5–4, to see if the presence of Temporomandibular Disorders affects spinal mobility, axial rigidity, and fear of movement (kinesiophobia). Assessments will be conducted in person at the Neurology Outpatient Clinic of Hatay Mustafa Kemal University, during the medicated “ON” state. Data will explore potential biomechanical links between TMJ function and trunk control in PD, contributing to understanding of how jaw and spine mechanics may interact in this population.

Why it matters

Potential benefit: If differences are found, results could help guide physical therapy approaches that address both TMJ and spinal mobility in PD.

How similar studies have gone: Previous work has shown links between PD-related rigidity and craniofacial function; this study adds observational data on TMD co-occurrence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed with Parkinson's disease
* Modified Hoehn \& Yahr stages 1.5 to 4
* Mini-Mental State Examination (MMSE) score ≥ 24
* Evaluated during the medication "ON" state

Exclusion Criteria:

* History of cervical, lumbar, maxillofacial, or temporomandibular joint surgery -Acute orthopedic or severe rheumatologic disease (e.g., advanced ankylosing spondylitis)
* Additional comorbid neurological disorders (e.g., stroke, multiple sclerosis)
* Complete edentulism or severe disruption of oral anatomy
* Ongoing acute dental pain
* Pregnancy or suspected pregnancy
* Severe psychiatric disorders

Where it's running

  • Hatay Mustafa Kemal Universty
    Hatay, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • UX-DA003 injections for Parkinson's disease

    This early-phase trial tests whether injecting UX-DA003 is safe and may help motor symptoms in people with Parkinson's whose response to standard treatments has declined.

    Recruiting Early Phase 1 The First Affiliated Hospital of Anhui Medical University · Hefei, Anhui · NCT07911670

  • Strength and dual-task training to help people with Parkinson’s improve strength and function

    This trial tests three levels of physiotherapy, including progressive resistance training with and without cognitive dual-task and instability components, to see if they improve muscle strength, body composition, and physical function in adults with Parkinson’s or related syndromes.

    Recruiting University of Valencia · Valencia, Valencia · NCT07907302

  • A 12-Week Trial of Flexilev with the OraFID Device and App for Parkinson's

    This study tests whether taking small, precise doses of Flexilev with the OraFID dosing device and Levilog app is acceptable and helps people with Parkinson's manage their medicine.

    Recruiting at 2 sites Phase 4 Navamedic AB · Stockholm, Stockholm County and 4 other locations · NCT07839793

  • Integrated Motor-Cognitive Training in Parkinson's Disease

    This study tests a combined motor and cognitive rehabilitation program to see if people with Parkinson’s disease can stick with it and show early signs of benefit.

    Recruiting University Hospital of Ferrara · Ferrara, FE · NCT07833748

  • VIM0423 for Parkinson's Tremor in Adults Not Fully Controlled by Dopaminergic Therapy

    A Vima Therapeutics study tests whether the oral drug VIM0423 can reduce tremor in adults with Parkinson’s disease who still have tremor despite dopaminergic treatment.

    Recruiting at 4 sites Phase 2 Vima Therapeutics · Scottsdale, Arizona and 29 other locations · NCT07804615

  • Optimizing Adaptive Deep Brain Stimulation for Parkinson's Disease

    This study tests whether using ongoing brain signals gathered during daily life can improve adaptive deep brain stimulation for people with Parkinson's who have motor fluctuations.

    Recruiting University of California, Davis · Davis, California · NCT07798271

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.